{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T06:07:31Z","timestamp":1649138851812},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,1,24]],"date-time":"2012-01-24T00:00:00Z","timestamp":1327363200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatr Q"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s11126-011-9203-1","type":"journal-article","created":{"date-parts":[[2012,1,23]],"date-time":"2012-01-23T16:45:20Z","timestamp":1327337120000},"page":"335-341","source":"Crossref","is-referenced-by-count":1,"title":["Perphenazine Suspension: A New, Old Treatment, Side Effects and Continuous Use"],"prefix":"10.1007","volume":"83","author":[{"given":"Pascale","family":"Chrisphonte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert B.","family":"Ostroff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A.","family":"Rosenheck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,1,24]]},"reference":[{"issue":"12","key":"9203_CR1","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","volume":"353","author":"JA Lieberman","year":"2005","unstructured":"Lieberman JA, Stroup S, McEvoy J, Swartz M, Rosenheck R, Perkins D, Keefe RSE, Davis S, Davis CE, Hsiao J, Severe J, Lebowitz B, for the CATIE Investigators: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia: Primary efficacy and safety outcomes of the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial. New England Journal of Medicine 353(12):1209\u20131223, 2005.","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"9203_CR2","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1176\/appi.ajp.163.12.2080","volume":"163","author":"RA Rosenheck","year":"2006","unstructured":"Rosenheck RA, Leslie D, Sindelar J, Miller EA, Lin H, Stroup S, McEvoy J, Davis S, Keefe RSE, Swartz M, Perkins D, Hsiao J, Lieberman JA: Cost-effectiveness of second generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia. American Journal of Psychiatry 163(12):2080\u20132089, 2006.","journal-title":"American Journal of Psychiatry"},{"key":"9203_CR3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1192\/bjp.bp.108.050088","volume":"193","author":"DD Miller","year":"2008","unstructured":"Miller DD, Caroff SN, Davis SM, Rosenheck RA, McEvoy JP, Saltz BL, Swartz MS, Keefe RSE, Stroup TS, Lieberman JA: Extrapyramidal side effects of second generation antipsychotics and perphenazine in a randomized trial of treatment for chronic schizophrenia. British Journal of Psychiatry 93:279\u2013288, 2008.","journal-title":"British Journal of Psychiatry"},{"issue":"4","key":"9203_CR4","doi-asserted-by":"crossref","first-page":"463","DOI":"10.4088\/JCP.07m03890yel","volume":"71","author":"SW Woods","year":"2010","unstructured":"Woods SW, Morgenstern H, Saksa JR, Walsh BC, Sullivan MC, Money R, Hawkins KA, Gueorguieva RV, Glazer WM: Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: A prospective cohort study. The Journal of Clinical Psychiatry 71(4):463\u2013474, 2010.","journal-title":"The Journal of Clinical Psychiatry"},{"key":"9203_CR5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1192\/bjp.bp.106.035063","volume":"191","author":"RA Rosenheck","year":"2007","unstructured":"Rosenheck RA. Considerations for evaluating the cost-effectiveness of reducing tardive dyskinesia with second generation antipsychotics. British Journal of Psychiatry 191:238\u2013245, 2007.","journal-title":"British Journal of Psychiatry"}],"container-title":["Psychiatric Quarterly"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11126-011-9203-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11126-011-9203-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11126-011-9203-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T03:24:55Z","timestamp":1559359495000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11126-011-9203-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1,24]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["9203"],"URL":"https:\/\/doi.org\/10.1007\/s11126-011-9203-1","relation":{},"ISSN":["0033-2720","1573-6709"],"issn-type":[{"value":"0033-2720","type":"print"},{"value":"1573-6709","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,1,24]]}}}